Table 1.

Study schema^a and evaluable modified intent-to-treat population

	Visit 1 (screening, Week 0)	Visit 2 (end of no-drug qualification period, Week 4)	Visit 5 (end of single-blind placebo treatment period, Week 10)	Visit 12 (end of double-blind treatment period, Week 23)
Evaluable mITT	N = 325	N = 324	N = 238	N = 229
FSDS-DAO	X	X	X	X
FSFI	X	X	X	X
GAQ			X	X
WITS-9			X	X

FSDS-DAO = Female Sexual Distress Scale-Desire/Arousal/Orgasm; FSFI = Female Sexual Function Index; GAQ = General Assessment Questionnaire; mITT = modified intent-to-treat; WITS-9 = Women’s Inventory of Treatment Satisfaction

^aThe FSEP-R was completed after each sexual encounter